BCL2L1 and neoplasm: We then assessed whether the expression of Bcl-2, Bcl-xL, survivin, p21 and cyclin D1 correlates with various clinical and pathologic parameters, including gender, location and size of the tumor, lymph node metastasis, histologic grade, depth of tumor invasion/clinical stage and overall survival.